- Deep Vein Thrombosis (DVT) Awareness Bus to visit Minneapolis
- NATT Medicare/Medicaid Victory
- NATT RECEIVES GRANT FOR WEBSITE ENHANCEMENT FROM JOHNSON & JOHNSON
- MASAB RECOMMENDS EXPANDING NATT PATIENT ADVOCACY TO INCLUDE ATRIAL FIBRILLATIONAntithrombin Deficiency An In-Depth Guide for Patients and Health Care Providers By Dr. Stephan Moll
- Inherited antithrombin deficiency: a review
- Protein C deficiency - Haemophilia Volume 14, Issue 6, Pages 1214-1221
- Protein S deficiency: a clinical perspective- Haemophilia Volume 14, Issue
- Women’s Health Story by Andra James, MD, Duke University
- The Evolving Story of Pregnancy Outcome, Thromboembolism and Thrombophilia Story by Michael J. Paidas, M.D.
- Air Travel and DVT by Cynthia A. Kos
FDA PANEL RECOMMENDS APPROVAL OF NEW ORAL ANTICOAGULANT FOR HIP/KNEE SURGERY - NATT Testifies in Support
- Blood Clot Statistics Vary, But All Experts Agree the Numbers are Staggering
- NATT Launches Nationwide Chapter Development Strategy
- NATT-MN Announces September Support Group Meeting
- Family Testing for Clotting Disorders By: Elizabeth Varga, MS
- INR Self Testing Article by Dr. Stephan Moll & Dr. Jack Ansell
- INR Home Monitoring Triumphs! CMS Expands Coverage
- Owning My Coagulation Health Management by David Henry
- NATT Announces New Stoplight Risk Evaluation Tool
Athletes and Blood Clots by Stephan Moll M.D., Edward Libby M.D. and William Roberts M.D.
Blood Clots in Children and Young Adults
Antiphospholipid Syndrome (APS) Written by: Jan M. Pankey, M.D.
Blood clots can’t stop them… not even contain them! Story by Roland Varga
Venous Stress Disorder Article by Dr. Stephan Moll, Chapel Hill, North Carolina, and Dr. Susan R. Kahn, Montreal, Canada
NATT CREATES DVT/PE MORBIDITY AND MORTALITY MAP
Hip-Knee Replacement Blood Clot Prevention Drug Advances
Beverly Thao's Story By Beverly Thao
Harold Mitchell's Story by Harold Mitchell
Cedric Bills' Story by Cedric Bills
Jeanne Krull's Story by Jeanne Krull
Jessica Earley's Story
Jennifer Gray's Story by Jennifer Gray
Jim Fenton's Story
Nicole De Jong's Experience with Cerebral Venous Thrombosis
Pam Parrianna saved by Good Morning America Health Story on Blood Clots
The other Side of Nursing A Patient's Story By Christa Larson
Velton Wainwright Tudor’s Story
Lisa Boyd's Story by Lisa Boyd
Lynn Levitt's Story
Andy Morris's Story
New Antithrombin Drug, ATryn, Approved by FDA on February 9, 2009.
FDA Advisory Committee Recommends GTC Biotherapeutics' ATryn* (antithrombin [Recombinant])
Inherited Antithrombin Deficiency